HeartSciences (HSCS) Shares Outstanding (2021 - 2026)

HeartSciences (HSCS) has reported Shares Outstanding (Entity) for 6 consecutive years, with $2.6 million the latest figure, recorded in Q2 2026.

• Quarterly Shares Outstanding (Entity) rose 134.6% year-over-year to $2.6 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $2.6 million (up 134.6% YoY) and the FY2026 annual result came in at $2.6 million, up 134.6% from the prior year.
• Shares Outstanding (Entity) fell to $2.6 million in Q2 2026 per HSCS's latest filing, from $3.1 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for HSCS reached as high as $3.1 million in Q4 2025 and fell as low as $33239.0 in Q1 2022.
• A 5-year average of $740074.9 and a median of $352520.0 in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) surged 36.57% — and 2024, when it jumped 749.42%.
• Year by year, Shares Outstanding (Entity) stood at $82105.0 in 2022, then soared by 36.57% to $112134.0 in 2023, then jumped by 745.26% to $947821.0 in 2024, then jumped by 224.02% to $3.1 million in 2025, then declined by 14.51% to $2.6 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $2.6 million, $3.1 million, and $1.3 million for Q2 2026, Q4 2025, and Q3 2025 respectively.